# A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

> **NCT07631000** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 37 (estimated)

## Conditions studied

- Gastric Cancer
- Gastroesophageal-junction Cancer

## Interventions

- **DRUG:** Cadonilimab

## Key facts

- **NCT ID:** NCT07631000
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-27
- **Primary completion:** 2029-05-27
- **Final completion:** 2029-05-27
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631000, "A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07631000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*